Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience.
作者信息
Voulgari Paraskevi V, Venetsanopoulou Aliki I, Epagelis Efstratios K, Alamanos Yannis, Takalou Ioanna, Drosos Alexandros A
出版信息
Ann Rheum Dis. 2007 Feb;66(2):270-1. doi: 10.1136/ard.2006.058735. Epub 2006 Oct 26.
Abstract
摘要
相似文献
1
Infliximab in refractory psoriatic arthritis with severe psoriasis: a 2-year experience.英夫利昔单抗治疗伴有重度银屑病的难治性银屑病关节炎：两年经验
Ann Rheum Dis. 2007 Feb;66(2):270-1. doi: 10.1136/ard.2006.058735. Epub 2006 Oct 26.
2
Response of severe psoriasis to infliximab.重度银屑病对英夫利昔单抗的反应。
Dermatology. 2002;204(2):156-7. doi: 10.1159/000051840.
3
Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.英夫利昔单抗治疗后银屑病皮肤病变的愈合以及对免疫抑制药物耐药的银屑病关节炎的改善。
Ann Rheum Dis. 2005 Nov;64(11):1665-7. doi: 10.1136/ard.2005.036178.
4
Tumor necrosis factor (TNF) inhibitors revolutionalized therapy for both psoriasis and psoriatic arthritis. Foreword.肿瘤坏死因子（TNF）抑制剂彻底改变了银屑病和银屑病关节炎的治疗方法。前言。
Am J Clin Dermatol. 2014 Feb;15 Suppl 1:S3-4. doi: 10.1007/s40257-013-0058-0.
5
Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.肿瘤坏死因子α阻断剂对活动性银屑病和银屑病关节炎患者皮肤及滑膜组织的早期影响
Ann Rheum Dis. 2004 Jul;63(7):769-73. doi: 10.1136/ard.2003.018085.
6
TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.肿瘤坏死因子-α在银屑病和银屑病关节炎分子靶向治疗中的应用
Postgrad Med J. 2016 Mar;92(1085):172-8. doi: 10.1136/postgradmedj-2015-133419. Epub 2015 Dec 30.
7
TNFalpha therapy in psoriatic arthritis and psoriasis.肿瘤坏死因子α疗法在银屑病关节炎和银屑病中的应用。
Ann Rheum Dis. 2004 Jul;63(7):755-8. doi: 10.1136/ard.2004.020719.
8
Infliximab in psoriasis and psoriatic arthritis.英夫利昔单抗治疗银屑病和银屑病关节炎。
BioDrugs. 2013 Jan;27 Suppl 1:13-23. doi: 10.1007/BF03325638.
9
Anti-tumor necrosis factor alpha therapy in psoriatic arthritis and psoriasis.抗肿瘤坏死因子α疗法在银屑病关节炎和银屑病中的应用。
Arch Dermatol. 2001 Jun;137(6):784-5.
10
Infliximab monotherapy for refractory psoriasis: preliminary results.英夫利昔单抗单药治疗难治性银屑病：初步结果。
Int J Immunopathol Pharmacol. 2004 Sep-Dec;17(3):373-80. doi: 10.1177/039463200401700317.
引用本文的文献
1
Advances in nanomedicine for the treatment of ankylosing spondylitis.纳米医学在治疗强直性脊柱炎方面的进展。
Int J Nanomedicine. 2019 Oct 29;14:8521-8542. doi: 10.2147/IJN.S216199. eCollection 2019.
2
A case report of a psoriatic arthritis patient on hemodialysis treated with tumor necrosis factor blocking agent and a literature review.一 例 行 血 液 透 析 的 类 风 湿 关 节 炎 患 者 采 用 肿 瘤 坏 死 因 子 阻 断 剂 治 疗 的 病 例 报 告 及 文 献 回 顾。
Clin Rheumatol. 2010 Dec;29(12):1455-9. doi: 10.1007/s10067-010-1485-4. Epub 2010 May 21.
3
Ankylosing spondylitis: recent breakthroughs in diagnosis and treatment.强直性脊柱炎：诊断与治疗的最新突破
J Can Chiropr Assoc. 2007 Dec;51(4):249-60.
本文引用的文献
1
Healing of psoriatic skin lesions, and improvement of psoriatic arthritis resistant to immunosuppressive drugs, after infliximab treatment.英夫利昔单抗治疗后银屑病皮肤病变的愈合以及对免疫抑制药物耐药的银屑病关节炎的改善。
Ann Rheum Dis. 2005 Nov;64(11):1665-7. doi: 10.1136/ard.2005.036178.
2
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).英夫利昔单抗治疗银屑病关节炎皮肤和关节表现的持续获益：英夫利昔单抗多国银屑病关节炎对照试验（IMPACT）的结果
Arthritis Rheum. 2005 Apr;52(4):1227-36. doi: 10.1002/art.20967.
3
Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.英夫利昔单抗可改善银屑病关节炎的体征和症状：IMPACT 2试验结果
Ann Rheum Dis. 2005 Aug;64(8):1150-7. doi: 10.1136/ard.2004.032268. Epub 2005 Jan 27.
4
Assessment of patients with psoriatic arthritis: a review of currently available measures.银屑病关节炎患者的评估：现有测量方法综述
Arthritis Rheum. 2004 Jan;50(1):24-35. doi: 10.1002/art.11417.
5
Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.英夫利昔单抗治疗难治性银屑病关节炎：16例患者的12个月观察性研究
Ann Rheum Dis. 2004 Feb;63(2):156-61. doi: 10.1136/ard.2003.006775.
6
Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.英夫利昔单抗治疗银屑病关节炎的开放标签研究：炎症减轻的临床及磁共振成像测量
Arthritis Rheum. 2002 Oct 15;47(5):506-12. doi: 10.1002/art.10671.
7
Infliximab treatment in combination with cyclosporin A in patients with severe refractory rheumatoid arthritis.英夫利昔单抗联合环孢素A治疗重症难治性类风湿关节炎患者。
Ann Rheum Dis. 2002 Sep;61(9):822-5. doi: 10.1136/ard.61.9.822.
8
Clinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality.银屑病疾病严重程度和预后的临床指标：对其质量的批判性评估
Br J Dermatol. 1999 Aug;141(2):185-91. doi: 10.1046/j.1365-2133.1999.02963.x.
9
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.包含28个关节计数的改良疾病活动评分。类风湿关节炎患者前瞻性纵向研究中的开发与验证。
Arthritis Rheum. 1995 Jan;38(1):44-8. doi: 10.1002/art.1780380107.
10
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.美国风湿病学会。类风湿关节炎改善的初步定义。
Arthritis Rheum. 1995 Jun;38(6):727-35. doi: 10.1002/art.1780380602.
Zotero 插件